Zydus Wellness Ltd
NSE:ZYDUSWELL
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 473.85
2 397.8
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Zydus Wellness Ltd
Zydus Wellness Ltd
Cash Equivalents
Zydus Wellness Ltd
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zydus Wellness Ltd
NSE:ZYDUSWELL
|
Cash Equivalents
₹1.6B
|
CAGR 3-Years
26%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
|
Tata Consumer Products Ltd
NSE:TATACONSUM
|
Cash Equivalents
₹19.6B
|
CAGR 3-Years
17%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
|
|
Britannia Industries Ltd
NSE:BRITANNIA
|
Cash Equivalents
₹1.2B
|
CAGR 3-Years
22%
|
CAGR 5-Years
20%
|
CAGR 10-Years
1%
|
|
|
Patanjali Foods Ltd
NSE:PATANJALI
|
Cash Equivalents
₹4.3B
|
CAGR 3-Years
530%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
Marico Ltd
NSE:MARICO
|
Cash Equivalents
₹270m
|
CAGR 3-Years
-69%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
-24%
|
|
|
Nestle India Ltd
NSE:NESTLEIND
|
Cash Equivalents
₹1.2B
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
-6%
|
|
Zydus Wellness Ltd
Glance View
Zydus Wellness Ltd. engages in the business of development, production, marketing, and distribution of health and wellness products. The company is headquartered in Ahmedabad, Gujarat and currently employs 1,075 full-time employees. The firm operates as an integrated consumer company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands, such as Everyuth, Nutralite, Complan, Glucon-D, Sugarlite, Everyuth, Nycil and Sugar Free D’lite. Complan is a health food drink, scientifically designed for growing school children and contains nutrients along with milk protein. Sugar Free is a low-calorie sweetener, which is a replacement of sugar for the calorie-conscious, weight watchers and diabetics. Glucon-D is a glucose powder, which is available in various flavors variants with Vitamin D and Vitamin C. Everyuth offers a range of skincare products under the brand name of Everyuth Naturals. Nycil prickly heat and cooling powder brand and has also expanded portfolio into hand sanitizer category.
See Also
What is Zydus Wellness Ltd's Cash Equivalents?
Cash Equivalents
1.6B
INR
Based on the financial report for Jun 30, 2024, Zydus Wellness Ltd's Cash Equivalents amounts to 1.6B INR.
What is Zydus Wellness Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
44%
Over the last year, the Cash Equivalents growth was 13 891%. The average annual Cash Equivalents growth rates for Zydus Wellness Ltd have been 26% over the past three years , 44% over the past five years .
You don't have any saved screeners yet
